The Royal Marsden NHS Foundation Trust
The Royal Marsden NHS Foundation Trust
London, United Kingdom1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, cardiovascular disorder, heart disorder, injury, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, radiation injury, skin disorder, skin neoplasm | Enrolling by invitation | Not stated | 2025-10-01 | NCT06605833 |